Guest guest Posted August 5, 2010 Report Share Posted August 5, 2010 FDA Approves First-Ever Human Test Of Embryonic Stem Cell-Based Therapy. The New York Times (7/31, B1, Pollack) reported on the front of its Business Day section that the FDA has approved "the world's first authorized test in people of a therapy derived from human embryonic stem cells." The clinical trial "could offer the first glimpse of the safety and possible effectiveness of a technology that has been hailed for its vast medical promise but also embroiled in political and ethical controversy." The trial "will test cells developed by the Geron Corporation and the University of California, Irvine in patients with new spinal cord injuries." The AP (7/31, Seaman) reported that Geron "plans to enroll eight to 10 patients in the study at sites nationwide. The trial" for its GRNOPC1 therapy "will take about two years, with each patient being studied for one year." The Wall Street Journal (7/31, Gryta) noted that Geron began the study in early 2009, but it was stopped due to concerns in an animal study showing an increased frequency of small cysts within the injury site. Bloomberg News (7/31, Waters, ) added that Okarma, Geron's president and chief executive officer, said the FDA's decision strengthens the company's ability to start similar trials in the future. CNN (7/31, Landau), the USA Today (7/30, Vergano) "Science Fair" blog, the Financial Times (7/31, Cookson) and Politics Daily (8/2, Weber) also covered the story. Nandini K. Kumar Former Deputy Director General Sr. Grade Co-investigator NIH project National Institute of Epidemiology R 127, 3rd Avenue, TNHB, Ayapakkam, Chennai 600077 Ph : +91 44 26136214 Telefax : +91 44 26820891 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.